BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 96 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,454,181 | -9.3% | 239,707 | +3.4% | 0.01% | -13.3% |
| Q2 2023 | $3,806,370 | +119109.8% | 231,813 | +21.3% | 0.02% | +7.1% |
| Q1 2023 | $3,193 | +8.4% | 191,087 | +0.1% | 0.01% | -6.7% |
| Q4 2022 | $2,946 | -99.9% | 190,973 | +11.0% | 0.02% | +15.4% |
| Q3 2022 | $2,567,000 | +2.2% | 171,977 | +12.5% | 0.01% | 0.0% |
| Q2 2022 | $2,511,000 | -25.5% | 152,859 | -9.0% | 0.01% | -18.8% |
| Q1 2022 | $3,369,000 | -45.4% | 167,949 | -31.0% | 0.02% | -44.8% |
| Q4 2021 | $6,168,000 | -6.5% | 243,254 | -0.5% | 0.03% | -17.1% |
| Q3 2021 | $6,598,000 | +24.5% | 244,561 | +33.4% | 0.04% | +16.7% |
| Q2 2021 | $5,301,000 | +105.5% | 183,306 | +86.8% | 0.03% | +76.5% |
| Q1 2021 | $2,580,000 | +1117.0% | 98,121 | +866.8% | 0.02% | +750.0% |
| Q2 2020 | $212,000 | – | 10,149 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |